Immunobiology of IL-26
Related Posts
Armstrong A, Papp KA, Lebwohl M, Savage LJ, Yamanaka K, Vlase DE, Warham R, Lambert J, López Pinto JM, Wixted K, Thaçi D. Bimekizumab Impact[...]
Chou P, Ma E, Roberts A, Jeong C, Katz A, Yan MJ, Johnsen N, Nong Y, Yee M, Armstrong A. Differences in Prescription Patterns Among[...]
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis
Armstrong AW, Warren RB, Sofen H, Spelman L, Linaberry M, Becker B, Jou YM, Daamen C, Kimball AB. Deucravacitinib in Plaque Psoriasis After Inadequate Response[...]